55种药品将降价，最高可月省数千元

Core Viewpoint - The implementation of the 11th batch of national organized drug centralized procurement results in Hunan Province is set to significantly reduce drug prices, thereby alleviating the financial burden on patients [1][2]. Group 1: Drug Procurement and Implementation - A total of 55 drugs have been selected for centralized procurement, covering common medications for various conditions such as infections, allergies, tumors, diabetes, hypertension, and hyperlipidemia, as well as some treatments for rare diseases [1]. - The price reduction for selected drugs is substantial; for instance, the monthly cost of Nintedanib soft capsules for treating idiopathic pulmonary fibrosis has dropped from over 7000 yuan to just a few hundred yuan [1]. Group 2: Distribution and Quality Assurance - The selected enterprises are responsible for ensuring drug quality and supply, with a requirement to choose reputable distributors, ensuring at least three distributors per city to cover all participating medical institutions [2]. - Public medical institutions are mandated to prioritize the procurement and use of the selected drugs, with a prohibition on hindering the entry of these products into hospitals through restrictive conditions [2].